Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Dianthus Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 241
- +77 vs. Q4 2025
- Shares held
- 62.2M
- +15.4M (+32.8%) vs. Q4 2025
- Total value
- $5.18B
- +$3.25B (+168.5%) vs. Q4 2025
- New holders
- 97
- 83 more added
- Sold out
- 20
- 54 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 362,470 | $30.4M | 2.74% | −381,122−51.3% | Reduced |
| Sio Capital Management, LLC | 370,045 | $31.1M | 4.48% | −104,458−22.0% | Reduced |
| Spruce Street Capital LP | 373,274 | $31.3M | 7.53% | +75,837+25.5% | Added |
| Barclays PLC | 379,606 | $31.9M | 0.01% | +203,306+115.3% | Added |
| Artisan Partners Limited Partnership | 382,121 | $32.1M | 0.05% | +382,121 | New |
| Logos Global Management LP | 400,000 | $33.6M | 1.73% | +85,000+27.0% | Added |
| MPM Oncology Impact Management LP | 423,982 | $35.6M | 2.75% | +423,982 | New |
| Ameriprise Financial Inc | 429,127 | $36.0M | 0.01% | +273,964+176.6% | Added |
| Samlyn Capital, LLC | 431,115 | $36.2M | 0.62% | +431,115 | New |
| Woodline Partners LP | 433,457 | $36.4M | 0.14% | +220,370+103.4% | Added |
| Alliancebernstein L.P. | 926,071 | $38.2M | 0.01% | +91,688+11.0% | Added |
| Balyasny Asset Management LLC | 474,085 | $39.8M | 0.08% | +474,085 | New |
| Jennison Associates LLC | 485,136 | $40.7M | 0.03% | +485,136 | New |
| Goldman Sachs Group Inc | 548,010 | $46.0M | 0.01% | −29,009−5.0% | Reduced |
| Catalio Capital Management, LP | 560,308 | $47.0M | 9.82% | −93,264−14.3% | Reduced |
| Point72 Asset Management, L.P. | 643,599 | $54.0M | 0.09% | −522,489−44.8% | Reduced |
| Silverarc Capital Management, LLC | 654,746 | $54.9M | 6.47% | −95,390−12.7% | Reduced |
| UBS Group AG | 781,282 | $65.6M | 0.01% | +174,662+28.8% | Added |
| Farallon Capital Management, L.L.C. | 836,000 | $70.2M | 0.42% | +836,000 | New |
| Baker Bros. Advisors LP | 852,164 | $71.5M | 0.41% | +62,405+7.9% | Added |
| Braidwell LP | 899,364 | $75.5M | 2.52% | −374,571−29.4% | Reduced |
| Geode Capital Management, LLC | 916,211 | $76.9M | 0.00% | +239,553+35.4% | Added |
| Cormorant Asset Management, LP | 950,000 | $79.7M | 4.02% | +950,000 | New |
| Franklin Resources Inc | 968,182 | $81.2M | 0.02% | +505,356+109.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,019,813 | $85.6M | 1.01% | +1,019,813 | New |
| Polar Capital Holdings Plc | 1,076,009 | $90.3M | 0.39% | +71,281+7.1% | Added |
| Price T Rowe Associates Inc | 1,146,948 | $96.3M | 0.01% | +530,915+86.2% | Added |
| Fred Alger Management, LLC | 1,161,923 | $97.5M | 0.43% | +1,128,463+3,372.6% | Added |
| VR Adviser, LLC | 1,180,000 | $99.0M | 3.70% | +180,000+18.0% | Added |
| T. Rowe Price Investment Management, Inc. | 1,292,182 | $108.4M | 0.07% | +1,292,182 | New |
| State Street Corp | 1,398,913 | $117.4M | 0.00% | −108,706−7.2% | Reduced |
| Citadel Advisors LLC | 1,610,483 | $135.2M | 0.10% | +541,549+50.7% | Added |
| TCG Crossover Management, LLC | 1,676,624 | $140.7M | 4.03% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 1,946,667 | $163.4M | 18.08% | −470,000−19.4% | Reduced |
| Vanguard Capital Management LLC | 2,031,249 | $170.5M | 0.00% | +2,031,249 | New |
| Avidity Partners Management LP | 2,104,184 | $176.6M | 35.76% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 2,537,191 | $212.9M | 15.38% | +400,000+18.7% | Added |
| Wellington Management Group LLP | 2,595,783 | $217.8M | 0.04% | +92,593+3.7% | Added |
| Ra Capital Management, L.P. | 2,611,733 | $219.2M | 2.32% | +1,000,000+62.0% | Added |
| BlackRock, Inc. | 3,175,703 | $266.5M | 0.00% | +1,260,467+65.8% | Added |
| FMR LLC | 7,767,686 | $651.9M | 0.03% | +1,336,357+20.8% | Added |
| Great Point Partners LLC | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Public Sector Pension Investment Board | 0 | $0 | 0.00% | −48,477−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −48,400−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −45,833−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −39,480−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −32,100−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −26,249−100.0% | Sold out |
| Ishara Investments LP | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −23,694−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −16,829−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −16,708−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,510−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −9,715−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −7,008−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −1,856−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −769−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Iron Triangle Partners LP | – | – | – | – | Not filed |